Procaps Group, S.A Other Non-Current Liabilities 2020-2023 | PROCF

Procaps Group, S.A other non-current liabilities from 2020 to 2023. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Procaps Group, S.A Annual Other Non-Current Liabilities
(Millions of US $)
2022 $57
2021 $128
2020 $4
2020 $197
2019 $
2019 $
2018 $
Procaps Group, S.A Quarterly Other Non-Current Liabilities
(Millions of US $)
2023-09-30 $33
2023-06-30 $42
2023-03-31 $46
2022-12-31 $57
2022-09-30 $89
2022-06-30 $118
2022-03-31 $107
2021-12-31 $128
2021-09-30 $37
2021-06-30 $165
2021-03-31 $225
2020-12-31 $4
2020-09-30 $197
2020-06-30 $197
2020-03-31 $197
2019-12-31 $197
2019-09-30
2019-06-30
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49